Atlas Trials

Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis

Clinical trial NCT02651545 · COMPLETED

Trial details

NCT number
NCT02651545
Sponsor
State University of New York at Buffalo
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2014-02-01
Primary completion
2020-11-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.